Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks ...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the company, Ratings reports. Nine equities research ...

William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

Xenon Pharmaceuticals (($XENE)) has held its Q4 earnings call. Read on for the main highlights of the call. Xenon Pharmaceuticals’ recent earnings ...

VANCOUVER, British Columbia and BOSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, ...

Recompiled project, XenonRecomp does something similar, except for the PowerPC-equipped Microsoft Xbox 360 game console. Based around the triple-core IBM CPU codenamed ...

Wedbush lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $42 from $43 and keeps an Outperform rating on the shares. Most ...

Xenon Pharmaceuticals Inc (XENE) showcases robust pipeline progress and financial stability, while addressing challenges in ...

BURNABY, British Columbia — BURNABY, British Columbia — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $65.7 million in its fourth quarter. On a per-share basis, the Burnaby, British ...

Recaro has introduced the Xenon 1, a car seat designed to provide superior safety, comfort and convenience for children ages ...

The original Xenon processor’s architecture implements 3 PPC via the PowerPC instruction set created by IBM. Therefore, the ...